PRIMARY STUDY

Cannabidiol in Parkinson’s disease

Key Findings:  While these studies show promising results sample sizes were very small and duration of follow-up was very short thus the author concludes that more clinical trials need to occur to prove the efficacy of CBD in the treatment of PD.

Type of Study:  Meta-analysis

Study Result:  Inconclusive


Cannabinoids Studied:  Cannabidiol (CBD)

Phytocannabinoid Source:  Not Applicable

Chemotype:  Chemotype III

Form of Administration:  Not Applicable


Study Location(s):  Brazil

Year of Pub:  2020


Link to study